Taiwan FDA registration 5fee14621e9ca462ca7747b28fadc8e6
"Xiedi" expands the Evarepamycin coronary artery coating stent
TW: “希艾迪” 擴立安依芙雷帕黴素冠狀動脈塗藥支架
Taiwan·Risk Class 3·CID S.P.A.·Registered Oct 25, 2021 – Oct 25, 2026ActiveRegistration details
- Analysis ID
- 5fee14621e9ca462ca7747b28fadc8e6
- Customs Code
- DHA05603500700
Company information
- Manufacturer
- CID S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- BUDDY MEDICAL CO., LTD.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.0001 Cardiovascular stents
- Import Information
- Safety monitoring;; import
Dates and status
- Registration Date
- Oct 25, 2021
- Expiry Date
- Oct 25, 2026
About this record
Access comprehensive regulatory information for "Xiedi" expands the Evarepamycin coronary artery coating stent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5fee14621e9ca462ca7747b28fadc8e6 and manufactured by CID S.P.A.. The authorized representative in Taiwan is BUDDY MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices